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Summary
Background and objectives: Sleep apnea is highly prevalent in patients with heart disease.
However, the association between sleep apnea and ventricular arrhythmias is unclear. The
aim of this study was to examine the relationship between sleep apnea and electrophysio-
logic characteristics and clinical outcome after catheter ablation in patients having ventricular
arrhythmias.
Methods and results: Forty-four patients with ventricular tachycardia (VT) or premature ven-
tricular complexes (PVCs) without structural heart diseases (57% men; mean age: 55± 15 years)
underwent a sleep study. Subjects with an apnea—hypopnea index (AHI) ≥10/h were considered
to have sleep apnea. Electrophysiologic studies were performed on all patients, and 35 patients
underwent catheter ablation therapy. Seventeen patients (39%) had sleep apnea with an aver-
age AHI of 27± 17/h. Electrophysiologic characteristics of ventricular arrhythmias showed that
sites of VT/PVCs origin in the pulmonary artery and the aortic sinus of Valsalva were detected in
27% and 20% patients with sleep apnea, which was a relatively higher rate than that in patients
without sleep apnea (8% and 0%, respectively). Successful catheter ablation was achieved in
11 patients (85%) with sleep apnea and 17 (77%) without sleep apnea. During a mean follow-
up period of 13.5± 7.3 months after catheter ablation, 5 patients (45%) with sleep apnea and
1 patient (6%) without sleep apnea experienced recurrent VT/PVCs. Comparing the outcome
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between the two groups, the VT/PVCs recurrence rate was signiﬁcantly higher in patients with
sleep apnea than in those without sleep apnea (p = 0.02).
Conclusions: Ventricular arrhythmia patients with sleep apnea have a high recurrence of
arrhythmias after successful catheter ablation. Patients with ventricular arrhythmias should be
systematically assessed for sleep apnea owing to the potential detrimental effects of sleep apnea
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right ventricle under ﬂuoroscopic guidance. These three
catheters were used to record intracardiac local electro-
grams and to stimulate at the right ventricular apex (RVA),in the follow-up period.
© 2009 Japanese College of C
ntroduction
leep apnea is associated with heart diseases such as atrial
brillation [1], ischemic heart disease [2], and heart fail-
re [3]. A recent epidemiologic study reported a signiﬁcant
ncrease in the prevalence of nocturnal atrial ﬁbrillation,
onsustained ventricular tachycardia (VT), and premature
entricular complexes (PVCs) in subjects with severe sleep
pnea compared to those without sleep apnea [4,5]. Fur-
hermore, a previous study reported that sleep apnea
atients have a signiﬁcantly increased risk of cardiac-related
udden death between midnight and 06.00 h [6,7]. Another
eport showed that patients with untreated sleep apnea
ave a higher risk of recurrence of atrial ﬁbrillation after
uccessful cardioversion than those without known sleep
pnea [8]. However, limited data exist on the relationship
etween sleep apnea and ventricular arrhythmias.
Ventricular arrhythmias constitute a relatively small
nd distinct subset, occurring in patients even with-
ut detectable underlying heart disease. Detailed clinical
bservations and electrophysiologic studies led to a dif-
erentiation of VT into ‘repetitive monomorphic VT,’
nonsustained VT,’ and ‘frequent PVCs.’ Recently, radiofre-
uency catheter ablation has been shown to be an effective
nd safe treatment modality for idiopathic VT. However, the
nderlying mechanism of idiopathic VT is still a matter of
ebate because controversial ﬁndings have been reported
n a limited number of patients [9,10]. Although sporadic
eports have attempted to implicate hypoxia as one of the
echanisms of cardiac arrhythmias in humans [11], there is
lack of convincing proof to verify this claim.
The aim of this study was to examine the relationship
etween sleep apnea and electrophysiologic characteristics
nd follow-up after catheter ablation in patients having VT
ithout structural heart disease.
aterials and methods
tudy population
etween April 2004 and October 2007, 90 consecutive
atients (50% men; mean age: 49± 18 years) with VT or PVCs
ere referred to the Cardiology Department of Tsukuba Uni-
ersity Hospital, Tsukuba, Japan, for catheter ablation. The
election criteria for catheter ablation included potentially
atal arrhythmias or severe symptoms that were clearly
elated to frequent ventricular arrhythmias, inability of the
atient to tolerate treatment, or unsuccessful treatment
ith at least two antiarrhythmic drugs. The study group in
he present study consisted of 44 of the 90 patients. Study
ubjects were randomly selected from among the patients
ho were older than 20 years and who did not have any his-
t
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i
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eology. Published by Elsevier Ireland Ltd. All rights reserved.
ory of myocardial infarction, heart failure, valvular heart
isease, cardiomyopathy, obstructive lung disease, clinical
igns of central or peripheral nervous system impairment, or
istory of stroke. Initial assessment included historic data
ollection, routine blood tests, 12-lead electrocardiogra-
hy, and echocardiography. Sustained VT was deﬁned as
T lasting more than 30 s or causing hemodynamic dete-
ioration necessitating intervention to terminate the VT.
onsustained VT was deﬁned as three or more consecutive
entricular beats lasting less than 30 s and without hemody-
amic instability. The presence of coronary artery disease
>75% stenosis of any major epicardial vessel) was assessed
y stress testing and/or cardiac catheterization. Subjec-
ive sleepiness was assessed using Epworth Sleepiness Scale,
hich is a validated 8-item self-administered questionnaire
12]. Written informed consent was obtained from all sub-
ects, and the study protocol was approved by the Ethical
ommittee of the University of Tsukuba.
leep studies
leep evaluations of all 44 subjects were conducted
y a sleep specialist 2 days after the electrophysio-
ogic study with standard sleep studies, which were
erformed by monitoring of electroencephalogram, elec-
rooculogram, electromyogram, electrocardiogram, thora-
oabdominal excursions, pulse oximetry, and naso-oral
irﬂow using Alice 4 (Respironics, Pittsburgh, PA, USA).
Apnea was deﬁned as cessation of inspiration for at least
0 s. All such events were counted irrespective of the degree
f desaturation. Hypopnea was deﬁned as a reduction in air-
ow by at least 30% with a decrease in oxygen saturation
SaO2) by 4% or more for at least 10 s. The apnea—hypopnea
ndex (AHI) was calculated as the sum of apneic and hypop-
eic events per hour of sleep. An AHI threshold ≥10/h was
sed for the diagnosis of sleep apnea.
lectrophysiologic study and catheter ablation
ll patients underwent an invasive electrophysiologic study
n the fasting, unsedated state. Antiarrhythmic agents were
iscontinued for at least ﬁve half-lives before the study.
hree quadripolar electrode catheters were inserted per-
utaneously into the femoral vein and advanced to thehe right ventricular outﬂow tract (RVOT), and the His bun-
le area. A decapolar electrode catheter was also inserted
nto the very distal coronary sinus. The protocol for pre-
ature ventricular stimulation was to apply up to three
xtrastimuli at two basic cycle lengths of 600 and 400ms.
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Ventricular burst pacing was applied for 20 beats at cycle
lengths of 250—400ms at the RVA and RVOT. Mapping and
ablation were carried out with a deﬂectable quadripolar
catheter with 4-mm distal tip electrode. Both right and left
ventricular endocardial activation mapping during tachycar-
dia and pace mapping during sinus rhythm were performed
in the right and left ventricles to localize the sites of VT ori-
gin. In some patients, an electroanatomical mapping system
(CARTO, Biosense Webster, Inc., Diamond Bar, CA, USA) was
used for endocardial activation mapping to more precisely
identify the origin of tachyarrhythmias. Catheter ablation
was performed on 35 patients by applying radiofrequency
energy at the site where endocardial activation was the
earliest and where pace mapping displayed a QRS complex
matched to that of spontaneous VT/PVCs. Successful abla-
tion was deﬁned as complete abolition of sustained VT or
repetitive PVCs for at least 90min after intravenous infusion
of isoproterenol, adenosine triphosphate, or edrophonium.
Recurrences of VT/PVCs were originated from the same
focus, which were assessed by clinical symptoms, electro-
cardiogram, and the detection of more than 1500 beats/day
on 24-h Holter recordings at a follow-up visit between 1 and
2 months after catheter ablation.
Statistical analysisResults are expressed as mean± SD. Comparisons of
continuous variables between groups were made with
unpaired t-tests where appropriate and otherwise with the
Mann—Whitney test. Categorical variables were compared
by Fisher’s exact test or the 2 test, depending on appro-
l
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s
d
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Table 1 Patient characteristics.
Sleep apnea (n = 17
Male, n (%) 11 (65)
Age (years) 60± 15
BMI (kg/m2) 27.0± 3.4
Waist circumference (cm) 94± 10
Systolic blood pressure (mmHg) 127± 7
Diastolic blood pressure (mmHg) 72± 11
LVEDd (cm) 51± 3
LVESd (cm) 32± 4
LVEF (%) 67± 7
BNP level (pg/ml) 141± 322
PVCs per day (n) 20625± 13625
History
Hypertension, n (%) 6 (35)
Hypercholesterolemia, n (%) 3 (18)
Diabetes mellitus, n (%) 0 (0)
Angina pectoris, n (%) 1 (6)
Atrial ﬁbrillation, n (%) 2 (12)
Clinical classiﬁcation of arrhythmia
Sustained VT, n (%) 3 (18)
Nonsustained VT, n (%) 10 (59)
Repetitive PVCs, n (%) 4 (24)
BMI, bodymass index; LVEDd, left ventricular end-diastolic dimension; LV
ejection fraction; BNP, B-type natriuretic peptide; PVC, premature ven213
riateness. Values with p < 0.05 were considered signiﬁcant.
he odds ratio (OR) and 95% conﬁdence intervals (CI) for the
ssociation between recurrence of VT/PVCs were assessed
y univariate logistic regression.
esults
aseline data
leep apnea was found in 17 of 44 patients (39%). In 6
f these patients (14%), severe sleep apnea (AHI ≥30/h)
as observed. The clinical characteristics of both groups
re summarized in Table 1. The mean age of this cohort
as 55± 15 years old, 57% were men, and mean body
ass index (BMI) was 24.1± 3.8 kg/m2. Gender difference
etween patients with and without sleep apnea was not sta-
istically signiﬁcant. Patients with sleep apnea were older
han those without sleep apnea (60± 15 years vs 52± 14
ears, p = 0.02), and their BMI and waist circumference were
igniﬁcantly higher than those of patients without sleep
pnea (BMI, 27.0± 3.8 kg/m2 vs 22.3± 2.9 kg/m2, p < 0.01;
aist circumference, 94± 10 cm vs 80± 9 cm, p < 0.01).
ystolic blood pressure was signiﬁcantly higher in sleep
pnea patients (127± 7mmHg vs 118± 12mmHg, p < 0.01),
hereas no differences were found in diastolic blood pres-
ure and the rate of hypertension. The echocardiographic
eft ventricular end-diastolic dimension was signiﬁcantly
arger in patients with sleep apnea than in patients without
leep apnea (51± 3 cm vs 48± 6 cm, p = 0.03), whereas no
ifferences were found in the left ventricular end-systolic
imension or the left ventricular ejection fraction. There
) No sleep apnea (n = 27) p-Value
13 (48) 0.4
52± 14 0.02
22.3± 2.9 <0.01
80± 9 <0.01
118± 12 <0.01
68± 11 0.1
48± 6 0.03
32± 5 0.5
64± 9 0.1
67± 80 0.1
21283± 21553 0.5
4 (15) 0.1
5 (19) 0.9
1 (4) 0.4
0 (0) 0.2
3 (11) 1
11 (41) 0.2
12 (44) 0.5
4 (15) 0.5
ESd, left ventricular end-systolic dimension; LVEF, left ventricular
tricular complex; VT, ventricular tachycardia.
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Table 2 Sleep study data.
Sleep apnea
(n = 17)
No sleep apnea
(n = 27)
p-Value
AHI (n/h) 27 ± 17 4 ± 3 <0.01
OA (n/h) 10 ± 11 1 ± 1 <0.01
CA (n/h) 4 ± 5 0 ± 0 <0.01
4% ODI (n/h) 22 ± 16 4 ± 4 <0.01
Lowest SaO2 (%) 79 ± 13 89 ± 4 <0.01
Mean SaO2 (%) 94 ± 2 95 ± 2 0.01
Epworth sleepiness 7.2 ± 3.8 6.2 ± 4.0 0.2
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AHI, apnea—hypopnea index; OA, obstructive apnea; CA, central
apnea; ODI, oxygen desaturation index.
as no difference in clinical classiﬁcation of arrhythmias
etween the groups.
leep study data
he sleep study showed the mean AHI of patients with sleep
pnea to be 27± 17/h and that of patients without sleep
pnea to be 4± 4/h (Table 2). Comparison of patients with
nd without sleep apnea showed that sleep apnea patients
ad signiﬁcantly increased 4% oxygen desaturation index
ODI) (p < 0.01) and signiﬁcantly decreased mean and low-
st SaO2 values (p < 0.01; p = 0.01). The Epworth sleepiness
core was low in both groups and was not statistically dif-
erent between the two groups (7.2± 3.8 in sleep apnea
atients; 6.2± 4.0 in non-sleep apnea patients, p = 0.2). No
orrelation existed between the symptoms related to sleep
pnea (Epworth score) and disease severity (AHI value).
lectrophysiologic study data and outcome after
atheter ablation therapy
he electrophysiologic characteristics of ventricular
rrhythmias are shown in Table 3. During electrophysiologic
R
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Table 3 Electrophysiologic study ﬁndings and results of catheter
Sleep
Mechanism
Triggered activity, n (%) 15 (10
Monofocal, n (%) 13 (87
Multifocal, n (%) 2 (13)
Reentry, n (%) 0 (0)
Site of origin
RV endocardium, n (%) 7 (47)
RV epicardium, n (%) 0 (0)
Pulmonary artery, n (%) 4 (27)
LV endocardium, n (%) 2 (13)
LV epicardium, n (%) 0 (0)
Aortic sinus of Valsalva, n (%) 3 (20)
Successful ablation, n (%) 11/13
Recurrence after successful catheter ablation, n (%) 5/11 (
LV, left ventricle; RV, right ventricle.Y. Koshino et al.
tudies, VT or PVCs were induced in 15 of 17 patients (88%)
ith sleep apnea and 25 of 27 patients (93%) without sleep
pnea. Three patients with sleep apnea and 2 patients
ithout sleep apnea had more than one origin of VT/PVCs.
n patients with sleep apnea, sites of VT/PVCs origin were
etected, 27% of them in the pulmonary artery, 47% of
hem in the right ventricular (RV) endocardium, 20% of
hem in the aortic sinus of Valsalva, and 13% of them in the
eft ventricular (LV) endocardium. In patients without sleep
pnea, sites of VT/PVCs origin were detected, 8% of them in
he pulmonary artery, 72% of them in the RV endocardium,
% of them in the RV epicardium, 20% of them in the LV
ndocardium, and 4% of them in the LV epicardium. Sites of
T/PVCs origin in the pulmonary artery and the aortic sinus
f Valsalva were detected in 27% and 20% patients with
leep apnea, which was a relatively higher rate than that in
atients without sleep apnea (8% and 0%), but there was no
tatistical difference. There was no difference in the rate of
ther sites of VT/PVCs origin between the two groups. In 2
f 15 patients with sleep apnea and 3 of 25 patients without
leep apnea, the arrhythmias could not be eliminated by
adiofrequency catheter ablation either because adequate
adiofrequency energy could not be delivered safely to
void risk, the site of earliest ventricular activation could
ot be determined by electrophysiologic study, or a stable
osition of the ablation catheter could not be maintained.
n the remaining 35 patients, 11 patients (85%) with sleep
pnea and 17 patients (77%) without sleep apnea were
uccessfully treated by radiofrequency catheter ablation.
uring a follow-up period of 13.5± 7.3 months (range, 1—24
onths) after hospital discharge catheter ablation, VT/PVCs
ecurred in 5 patients (45%) with sleep apnea and in 1 (6%)
ithout. Comparing the outcome between the two groups,
he recurrence rate of VT/PVCs was signiﬁcantly higher in
atients with sleep apnea than in those without (p = 0.02).
ecurrent VT/PVCs origins were LV endocardium, aortic
inus of Valsalva, and RV endocardium in 5 patients with
leep apnea and RV endocardium in 1 patient without sleep
pnea. Table 4 shows that univariate analysis identiﬁed
igniﬁcant associations between recurrence of VT/PVCs and
ablation.
apnea (n = 15) No sleep apnea (n = 25) p-Value
0) 21(84) 0.3
) 19 (76) 0.7
3 (12) 1
4 (16) 0.3
18 (72) 0.2
2 (8) 0.5
2 (8) 0.2
5 (20) 0.7
1 (4) 1
0 (0) 0.05
(85) 17/22 (77) 0.6
45) 1/17 (6) 0.02
Sleep apnea and ventricular arrhythmias
Table 4 Unadjusted ORs and 95% CIs for recurrence of
VT/PVCs.
OR 95% CI p-Value
Age (years old) 1.04 0.98—1.12 0.21
BMI (kg/m2) 1.28 1.00—1.74 0.07
Waist circumference (cm) 1.13 1.02—1.28 0.03
Systolic blood pressure (mmHg) 1.02 0.94—1.11 0.57
LVEDd (cm) 1.05 0.89—1.27 0.56
LVEF (%) 1.06 0.93—1.21 0.37
AHI 1.11 1.02—1.24 0.03
4% ODI (n/h) 1.11 1.02—1.26 0.04
Mean SaO2 (%) 0.96 0.66—1.38 0.06
OR, odds ratio; CI, conﬁdence interval; VT, ventricular tachy-
cardia; PVC, premature ventricular complex; BMI, body mass
(
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VT/PVCs after catheter ablation for arrhythmias comparedindex; LVEDd, left ventricular end-diastolic dimension; LVEF, left
ventricular ejection fraction; AHI, apnea—hypopnea index; ODI,
oxygen desaturation index.
waist circumference (OR 1.13, 95% CI 1.00—1.28, p = 0.03),
AHI (OR 1.11, 95% CI 1.02—1.24, p = 0.03), and 4% ODI (OR
1.11, 95% CI 1.02—1.26, p = 0.04).
Discussion
The novel ﬁndings of the present study are that recurrence
of ventricular arrhythmias after successful catheter ablation
was more likely to occur in patients with sleep apnea than in
patients without sleep apnea (45% vs 6%). To our knowledge,
no previous reports exist that address the recurrence of ven-
tricular arrhythmias after catheter ablation in patients with
sleep apnea. This is the ﬁrst report to indicate the relation-
ship between ventricular arrhythmias and sleep apnea on
the basis of the analysis of electrophysiologic characteris-
tics of ventricular arrhythmias and data from sleep studies.
Furthermore, in this study, although 39% of the participants
with sleep apnea were signiﬁcantly older and had higher BMI,
waist circumference, and systolic blood pressure values than
those without sleep apnea as traditionally reported [13],
the presence of sleep apnea in this population of patients
could not be predicted according to symptoms of daytime
sleepiness.
The present study revealed a higher recurrence rate of
ventricular arrhythmias in patients with sleep apnea. The
mechanisms by which sleep apnea predisposes a person to
ventricular arrhythmias are not fully understood, but they
may include two contributing factors: activation of the sym-
pathetic nervous system induced by linkage to episodes of
hypoxemia and arousal, and temporary hemodynamic alter-
ations related to increased intrathoracic pressure changes
against the occluded upper airway.
The repetitive hypoxia and reoxygenation episodes are
characteristic of the patients with sleep apnea. Previous
reports showed a relationship between deoxyhemoglobin
and VT/PVCs [11,14,15]. Moreover, several studies reported
that in sleep apnea patients with hypoxia, a signiﬁcant
increase in PVC frequency was detected with decreasing
SaO2 [4,16]. In patients with sleep apnea, it has been
suggested that repetitive obstruction of normal breathing
during sleep induces hypoxemia and hypercapnia, which
w
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acting through the chemoreﬂexes) elicit increased sym-
athetic activity that induces VT/PVCs [17,18]. Peripheral
hemoreceptors, which primarily respond to blood oxy-
en level, were found to be highly sensitive in patients
ith sleep apnea. Enhanced chemoreﬂex sensitivity may
xplain the exaggerated sympathetic response during hypox-
mic episodes, resulting in autonomic activity-dependent
rrhythmias [19—23].
Another characteristic in sleep apnea is frequent arousal
esulting in sudden increases in sympathetic nervous activity
nd withdrawal of cardiac vagal activity. Those abrupt sym-
athetic changes induced by arousal may trigger arrhythmias
24,25]. Additionally, frequent arousal during sleeping
esults in sleep deprivation. Previous literature showed that
leep deprivation increases the sympathetic nervous activity
n the heart and signiﬁcantly increases the number of PVCs
ccurring during wakefulness [26—28].
Abrupt changes in intrathoracic pressure contribute to
orm causative substrate for occurrence of ventricular
rrhythmias in patients with sleep apnea. Repetitive massive
egative intrathoracic pressure is supposed to increase wall
tress and acute changes of ventricular performance may
lso contribute to occurrence of ventricular arrhythmias.
revious literature showed that producing large negative
ntrathoracic pressure induced increases in left and right
entricular volume and decreases in ejection fraction due
o increased left ventricular afterload [29,30]. Repetitive
oaded pressure impaired not only cardiac function but also
orphology and could lead to alternate the electrical con-
ucting system in the ventricle. Consequently, the affected
entricle would become a feasible substrate for occurrence
f ventricular arrhythmias.
A limitation of this study is that the sample size was
mall, and therefore it is possible that some of the com-
arisons that did not show any signiﬁcant difference in the
ites of VT/PVCs origin between the two groups could be
ue to type II statistical error. Furthermore, we found a
igher incidence of aortic sinus of Valsalva in those with
leep apnea but we had 3 vs 0 patients in these groups. This is
ardly sufﬁciently robust to allow for deﬁnitive conclusions.
econd, polysomnography may provide more detailed infor-
ation about sleep time and the type of sleep apnea, but in a
ew patients, we could not examine electroencephalograms,
lectrooculograms, electromyograms, or thoracoabdomi-
al excursions to assess sleep apnea because all study
atients undergoing evaluation by electrophysiologic study
r catheter ablation therapy for ventricular arrhythmias
ad various other disease conditions. Under these circum-
tances, we felt that full polysomnography could impose
ndue stress on these patients. Nevertheless, this is a valid
pproach to monitoring respiratory function during sleep.
onclusion
n conclusion, we found that ventricular arrhythmia patients
ith sleep apnea have a higher rate of recurrence ofith non-sleep apnea patients. Our data also showed that
leep apnea in patients with VT/PVCs was associated with
ew symptoms of daytime sleepiness. Consequently, we pro-
ose that patients with ventricular arrhythmias should be
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